Aqua Bio Technology ASA (ABT.OL)
NOK 6.93
(0.0%)
NOK 6.93
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2021 | 1.55 Million NOK | 250.99% |
| 2020 | 444.37 Thousand NOK | -50.15% |
| 2019 | 891.46 Thousand NOK | 1.52% |
| 2018 | 878.13 Thousand NOK | -27.65% |
| 2017 | 1.21 Million NOK | 0.0% |
| 2016 | - NOK | -100.0% |
| 2015 | 383.88 Thousand NOK | -60.92% |
| 2014 | 982.32 Thousand NOK | -79.43% |
| 2013 | 4.77 Million NOK | 179.22% |
| 2012 | 1.71 Million NOK | 807.15% |
| 2011 | 188.53 Thousand NOK | 51.55% |
| 2010 | 124.4 Thousand NOK | 0.0% |
| 2009 | - NOK | -100.0% |
| 2008 | 4.78 Million NOK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2021 FY | 1.55 Million NOK | 250.99% |
| 2020 FY | 444.37 Thousand NOK | -50.15% |
| 2019 FY | 891.46 Thousand NOK | 1.52% |
| 2018 FY | 878.13 Thousand NOK | -27.65% |
| 2017 FY | 1.21 Million NOK | 0.0% |
| 2016 FY | - NOK | -100.0% |
| 2016 Q1 | - NOK | -100.0% |
| 2016 Q2 | - NOK | 0.0% |
| 2016 Q3 | - NOK | 0.0% |
| 2016 Q4 | - NOK | 0.0% |
| 2015 FY | 383.88 Thousand NOK | -60.92% |
| 2015 Q3 | 147.28 Thousand NOK | 0.0% |
| 2015 Q4 | 80.09 Thousand NOK | -45.62% |
| 2015 Q1 | 156.5 Thousand NOK | 130.53% |
| 2015 Q2 | - NOK | -100.0% |
| 2014 Q3 | 607.59 Thousand NOK | 83.35% |
| 2014 Q1 | 555.97 Thousand NOK | 52.6% |
| 2014 Q2 | 331.38 Thousand NOK | -40.4% |
| 2014 FY | 982.32 Thousand NOK | -79.43% |
| 2014 Q4 | -512.62 Thousand NOK | -184.37% |
| 2013 FY | 4.77 Million NOK | 179.22% |
| 2013 Q4 | 364.34 Thousand NOK | 28.19% |
| 2013 Q3 | 284.23 Thousand NOK | -92.13% |
| 2013 Q2 | 3.61 Million NOK | 604.39% |
| 2013 Q1 | 513.03 Thousand NOK | -7.18% |
| 2012 Q1 | 11.93 Million NOK | 18185.33% |
| 2012 FY | 1.71 Million NOK | 807.15% |
| 2012 Q4 | 552.73 Thousand NOK | 220.5% |
| 2012 Q3 | 172.46 Thousand NOK | 44.15% |
| 2012 Q2 | 119.63 Thousand NOK | -99.0% |
| 2011 Q1 | 2173.00 NOK | -98.25% |
| 2011 Q4 | 65.25 Thousand NOK | 137.31% |
| 2011 FY | 188.53 Thousand NOK | 51.55% |
| 2011 Q3 | 27.5 Thousand NOK | -92.46% |
| 2011 Q2 | 364.6 Thousand NOK | 16678.65% |
| 2010 Q2 | - NOK | 0.0% |
| 2010 FY | 124.4 Thousand NOK | 0.0% |
| 2010 Q4 | 124.4 Thousand NOK | 0.0% |
| 2010 Q1 | - NOK | 0.0% |
| 2010 Q3 | - NOK | 0.0% |
| 2009 FY | - NOK | -100.0% |
| 2008 FY | 4.78 Million NOK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Arctic Bioscience AS | 33.75 Million NOK | 95.379% |
| ArcticZymes Technologies ASA | 118.93 Million NOK | 98.689% |
| BerGenBio ASA | 354 Thousand NOK | -340.594% |
| Hofseth BioCare ASA | 194.87 Million NOK | 99.2% |
| PCI Biotech Holding ASA | 2.99 Million NOK | 47.836% |
| Thor Medical ASA | - NOK | -Infinity% |
| Ultimovacs ASA | - NOK | -Infinity% |